Gregory Harper
CIK 1744952 · View on SEC EDGAR ↗
First SEC filing: June 27, 2018 · Latest: June 27, 2018
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| March 9, 2021 | STIM | S | 5,524 | $14.65 | $80,927 | 162,554 Direct | -3.29% | Disposed | -78.6% (price as of 2026-08-20) |
| Jan. 21, 2021 | STIM | S | 2,969 | $18.21 | $54,065 | 150,993 Direct | -1.93% | Disposed | -82.8% (price as of 2026-08-20) |
| Dec. 16, 2019 | STIM | P | 10,000 | $4.40 | $44,000 | 75,480 Direct | +15.27% | Acquired | -28.8% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 3, 2021 | STIM | Performance Restricted Stock Unit | Common Stock (15,000) | — | — | 15,000 | Acquired |
| July 24, 2019 | STIM | Employee Stock Option (Right to Buy) | Common Stock (19,213) | $3.19 | Oct. 11, 2026 | 19,213 | Disposed |
| April 22, 2019 | STIM | Employee Stock Option (Right to Buy) | Common Stock (35,000) | $3.19 | Oct. 11, 2026 | 35,000 | Disposed |
| March 8, 2019 | STIM | Employee Stock Option (right to buy) | Common Stock (19,829) | $16.42 | March 8, 2029 | 19,829 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 3 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| June 27, 2018 | STIM | Employee Stock Option (Right to Buy)→ Common Stock (76,536) | 76,536 | Direct |
| June 27, 2018 | STIM | Employee Stock Option (Right to Buy)→ Common Stock (12,085) | 12,085 | Direct |
| June 27, 2018 | STIM | Employee Stock Option (Right to Buy)→ Common Stock (25,203) | 25,203 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
STIM
Former Vice President, R&D and Clinical(4)| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2020 | $342,000 | — | — | — | $110,124 | — | — | $718,319 |
| 2019 | $330,000 | — | — | — | — | — | — | $945,701 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.